Applied UV Announces Award of Sole Source Contract for Airocide FDA Class II Medical Device to International Dealer
Airocide will be deployed in public hospitals in Pakistan
Expands its global footprint with distribution now in 52 countries
Applied UV, Inc. (NasdaqCM: AUVI ) (“Applied UV” or the “Company”), a pathogen removal technology company that applies the power of narrow range ultraviolet (“UVC”) light for surfaces and catalytic bioconversion technology for the air purification to destroy pathogens safely, thoroughly, and automatically, announced that it has expanded its global distribution reach with our distributor, M/S Novatek Pakistan, who has been appointed as sole supplier of Airocide air purification systems for public hospitals through government tender for KPK province in Pakistan.
This press release is multimedia. See the full version here: https://www.businesswire.com/news/home/20220609005149/en/
(Graphic: Business Wire)
Distributor partner of Applied UV, M/S Novatek Pakistan has extensive experience in dealing with the Pakistani government and has already won a similar government tender with the installation of 657 Airocide air purification systems installed in all the countries.
Mr. Munawwar Zahid, CEO of M/S Novatek Pakistan said, “M/S Novatek Pakistan is proud to be the sole distributor of the patented Airocide technology which has been developed for NASA and is listed as a Class 1 medical device. II from the FDA allowing us to We were selected to partner with Airocide because we knew their air purification solutions are best in class, which have been deployed and used by globally recognized brands around the world to protect against SARS-COV-2 and other harmful airborne pathogens, even those too small to filter out.”
John Andrews, Managing Director of Applied UV, said, “We are proud to partner with M/S Novatek Pakistan and appreciate the trust they have placed in our suite of Airocide air purification solutions. Improving indoor air quality in all indoor public places, especially public hospitals, protecting facilities, staff and the patients who frequent them from dangerous pathogens is at the center of efforts by governments around the world whole.With the implementation of these government guidelines and standards that businesses must use to improve indoor air quality, our air purification solutions are best-in-class tools to use as the global economy begins to reopen, after the pandemic As a company, we are very aware of the great importance of improving the circle of care by protecting frontline health care around the world after this three-year pandemic. We look forward to working with M/S Novatek, we are extremely confident that our air purification solutions will help them achieve their stated goals.”
Mr. Zahid further stated, “We are grateful for the invaluable business relationship we share with Applied UV and for always being by our side. The support, dedication, professionalism and hard work of every member of Applied UV team have contributed greatly to the success of this mutual business.Airocide is something of great value in Pakistan due to its filterless technology and eco-friendly properties.We are seeing massive demand for Airocide in the coming year. We have enjoyed a very successful seven-year partnership and look forward to many more.”
About Applied UVs
Applied UV is focused on developing and acquiring technologies that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries – SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“Munn Works”). SteriLumen’s Airocide® air purifying devices are research backed, clinically proven and developed for NASA with assistance from the University of Wisconsin. Airocide® is listed as an FDA Class II medical device, uses proprietary photocatalytic bioconversion (PCO) technology that draws air into a reaction chamber that converts harmful molds, microorganisms, pathogens into airborne, destructive VOCs, allergens, odors and bio-gases into harmless water vapor and green carbon dioxide without producing ozone or other harmful by-products. Airocide® applications include healthcare, hospitality, grocery chains, winemaking facilities, commercial real estate, schools, dental offices, post-harvest, grocery stores, facilities of cannabis and houses. SteriLumen’s Connected Platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, completely and automatically, addressing the challenge of hospital-acquired infections (“HAI”). Intended for use in high customer turnover facilities such as hospitals, hotels, commercial facilities and other public spaces, the company’s Lumicide™ platform uses UVC LEDs in several patented designs for the infection control in and around high traffic areas, including sinks and toilets, killing bacteria, viruses and other pathogens residing on hard surfaces near appliances. The company’s patented drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical, pathogen-intensive location.
For more information about Applied UV, Inc. and its affiliates, please visit the following websites: https://www.applieduvinc.com/
The information contained in this document may contain “forward-looking statements”. Forward-looking statements reflect current beliefs about future events. When used in this press release, the words “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements in this press release regarding Applied UV’s management views regarding its business strategy, future results of operations and outlook for cash and capital resources. Forward-looking statements are based on the Company’s current expectations and assumptions regarding its business, economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical facts nor guarantees of future performance. We therefore advise you not to rely on any of these forward-looking statements. Factors or events that could cause the Company’s actual results to differ may arise from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including United States securities laws, the Company does not intend to update forward-looking statements to conform them to actual results.
For additional company information:
Applied UV Inc.
John F. Andrews
Applied UV Inc., CEO and Director
Brett Maas, General Manager